Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-12-022811)

Filing Details

Accession Number:: 0001209191-12-022811
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2012-04-11 19:03:14
Reporting Period:: 2012-03-20

Filing Date:: 2012-04-11
Accepted Time:: 2012-04-11 18:03:14
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1344413	Alexza Pharmaceuticals Inc.	ALXA	Pharmaceutical Preparations (2834)	770567768

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1101713	Gordon Ringold	325 E. Middlefield Ave Mountain View CA 94043		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2012-03-20	7,000	$0.00	0	No	5	G	Indirect	By the Vivian Robb Trust, as trustee
Common Stock	Acquisiton	2012-03-20	7,000	$0.00	123,925	No	5	G	Direct
Common Stock	Acquisiton	2012-04-09	100,000	$0.54	223,925	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	5	G	Indirect	By the Vivian Robb Trust, as trustee
No	5	G	Direct
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	9,276	Indirect	Held by spouse
Common Stock	9,276	Indirect	By the Gordon Ringold & Tanya Zarucki 1999 Reversible Trust, as co-trustee

Footnotes

All of the shares purchased were within a $1.00 price range between $0.533 to $0.550 per share, with a weighted average price per share of $0.54. Upon request, the Reporting Person will provide full information regarding the number of shares purchased at each separate price.